The repurposing of emerging small molecule compounds, especially those aimed at alleviating impairment in key cellular pathways, may also indirectly up-regulate BDNF or its signaling and therefore offer similar promise to more direct pharmacotherapies in HD. Here, BDNF is linked to Huntington disease.